| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |